Inolife: Emerging Leader in Needle-Free Injection Technologies

Sep. 29, 2017
Based in Irvine, CA, Inolife Inc. (OTC: INOL) is an emerging leader in needle free injection technologies. The Company commercializes a patented and FDA-approved needle free injection device under the trademark Inojex30. Inolife is also developing next generation needle free devices and technologies for use in various applications, including diabetes, immunology and analgesia. Inolife’s products are available online at www.inojex.com and through a growing network of distributors globally.

 Read More

Search Our Video Library


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President The NASDAQ Stock Market